Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11251
PUT
UFP Industries
UFPI
$4.96B
| $113K | ﹤0.01% |
1,000
-5,500
| -85% | -$709K |
|
11252
CALL
Sana Biotechnology
SANA
$1.06B
| $113K | ﹤0.01% |
69,100
+23,300
| +51% | +$69.5K |
|
11253
iShares MSCI Malaysia ETF
EWM
$330M
| $112K | ﹤0.01% |
4,586
-10,699
| -70% | -$267K |
|
11254
PUT
EastGroup Properties
EGP
$10.9B
| $112K | ﹤0.01% |
700
+500
| +250% | +$86.4K |
|
11255
PUT
NorthWestern Energy
NWE
$4.42B
| $112K | ﹤0.01% |
2,100
+100
| +5% | +$5.44K |
|
11256
CALL
Teekay
TK
$1.09B
| $112K | ﹤0.01% |
16,200
+14,500
| +853% | +$112K |
|
11257
CALL
Wintrust Financial
WTFC
$11B
| $112K | ﹤0.01% |
900
-500
| -36% | -$61.8K |
|
|
RVPH
11258
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $112K | ﹤0.01% |
3,100
+1,900
| +158% | +$52.9K |
|
11259
NB Bancorp
NBBK
$1.01B
| $112K | ﹤0.01% |
+6,210
| New | +$119K |
|
11260
PUT
Consensus Cloud Solutions
CCSI
$716M
| $112K | ﹤0.01% |
4,700
-2,000
| -30% | -$46.9K |
|
11261
RE/MAX Holdings
RMAX
$268M
| $112K | ﹤0.01% |
10,507
-87,876
| -89% | -$1.05M |
|
11262
BranchOut Food
BOF
$63.7M
| $112K | ﹤0.01% |
+65,171
| New | +$112K |
|
11263
PUT
Huron Consulting
HURN
$2.42B
| $112K | ﹤0.01% |
900
-600
| -40% | -$70.3K |
|
11264
Achieve Life Sciences
ACHV
$779M
| $112K | ﹤0.01% |
31,735
+31,729
| +528,817% | +$144K |
|
11265
MIRA Pharmaceuticals
MIRA
$32.8M
| $112K | ﹤0.01% |
+97,976
| New | +$128K |
|
11266
CALL
Babcock & Wilcox
BW
$1.53B
| $112K | ﹤0.01% |
68,100
+24,400
| +56% | +$51.6K |
|
11267
CALL
BioLife Solutions
BLFS
$1.72B
| $112K | ﹤0.01% |
4,300
-3,900
| -48% | -$97K |
|
11268
AirSculpt Technologies
AIRS
$247M
| $112K | ﹤0.01% |
+21,507
| New | +$132K |
|
11269
PUT
Alamo Group
ALG
$2.01B
| $112K | ﹤0.01% |
600
-5,400
| -90% | -$1.01M |
|
|
HTCO
11270
High-Trend International Group
HTCO
$26.9M
| $112K | ﹤0.01% |
+1,339
| New | +$48.2K |
|
|
AMRN
11271
Amarin Corp
AMRN
$297M
| $111K | ﹤0.01% |
11,495
+2,809
| +32% | +$30.1K |
|
|
XYF
11272
X Financial
XYF
$209M
| $111K | ﹤0.01% |
+13,382
| New | +$95K |
|
11273
Natural Gas Services Group
NGS
$490M
| $111K | ﹤0.01% |
4,157
-40,807
| -91% | -$958K |
|
11274
PUT
OGE Energy
OGE
$9.81B
| $111K | ﹤0.01% |
2,700
-3,600
| -57% | -$150K |
|
11275
PUT
VanEck Merk Gold Trust
OUNZ
$2.71B
| $111K | ﹤0.01% |
4,400
-17,900
| -80% | -$460K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.